Jean-Pierre Benitah Selected Research

Jean-Pierre Benitah Research Topics

Disease

11	Heart Failure 01/2022 - 07/2004
8	Cardiomegaly (Heart Hypertrophy) 01/2024 - 08/2004
5	Cardiac Arrhythmias (Arrythmia) 01/2024 - 10/2007
4	Hypertrophy 07/2013 - 08/2004
3	Myocardial Infarction 01/2022 - 07/2004
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 10/2018
2	Cardiotoxicity 01/2023 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 11/2021
2	Hypertension (High Blood Pressure) 01/2022 - 10/2007
2	Fibrosis (Cirrhosis) 11/2021 - 01/2018
2	Sudden Death 10/2018 - 08/2004
2	Polymorphic catecholergic ventricular tachycardia 07/2012 - 01/2009
1	Bidirectional tachycardia 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Hypoxia (Hypoxemia) 10/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Diabetic Cardiomyopathies 11/2021
1	Atrial Fibrillation 01/2021
1	Sick Sinus Syndrome 01/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2018
1	Long QT Syndrome 10/2018
1	Pulmonary Hypertension 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Right Ventricular Hypertrophy 01/2018
1	Heart Diseases (Heart Disease) 10/2015
1	Chronic Disease (Chronic Diseases) 10/2007
1	Atherosclerosis 10/2007
1	Atrial Remodeling 08/2004
1	Infarction (Infarctions) 07/2004

Drug/Important Bio-Agent (IBA)

5	erythromycin propionate-N-acetylcysteinateIBA 01/2023 - 11/2012
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2013
4	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022 - 01/2012
4	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 06/2016 - 07/2004
3	CalcineurinIBA 01/2024 - 01/2012
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2024 - 11/2012
3	CalciumIBA 11/2021 - 07/2020
3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 01/2009
3	AldosteroneIBA 01/2018 - 07/2004
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 07/2013 - 01/2012
2	AnthracyclinesIBA 01/2023 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2019
2	MonocrotalineIBA 10/2022 - 01/2018
2	MineralocorticoidsIBA 12/2019 - 04/2009
2	Mineralocorticoid Receptor AntagonistsIBA 01/2018 - 07/2004
2	EnzymesIBA 07/2013 - 01/2012
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 07/2013 - 01/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013 - 01/2012
1	tacrolimus binding protein 1BIBA 01/2024
1	Caffeine (No Doz)FDA LinkGeneric 01/2024
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2024
1	aniline (aniline hydrobromide)IBA 10/2022
1	ThiadiazolesIBA 10/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	junctophilinIBA 01/2022
1	SaltsIBA 01/2022
1	Calcium Channels (Calcium Channel)IBA 01/2022
1	Cardiac MyosinsIBA 01/2022
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2022
1	HexosaminesIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	sarcolipinIBA 07/2020
1	LaminsIBA 07/2020
1	Amino Acids FDA Link 10/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	LeptinIBA 01/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2013
1	Protein Kinases (Protein Kinase)IBA 11/2012
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2012
1	Hormones (Hormone)IBA 10/2007
1	GlucocorticoidsIBA 10/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2004
1	Interleukin-6 (Interleukin 6)IBA 07/2004
1	Messenger RNA (mRNA)IBA 07/2004

Therapy/Procedure

2	Therapeutics 11/2021 - 07/2020
1	Intravenous Infusions 01/2018